Filing Flows

Filing Flows › Lenz Therapeutics (LENZ) › Next earnings date

Lenz Therapeutics (LENZ) earnings

Lenz Therapeutics (LENZ) last reported on Oct 28, 2026: revenue $3.4M for the third quarter 2026. The next date is not set yet. It beat the EPS estimate in 40% of the quarters on record.

Beat rate40%

The last report

Lenz Therapeutics reported revenue of $3.4M for the third quarter 2026 (-73% Y/Y), net loss $31.0M: Product sales, net $2.6M, License revenue $785K. How it makes money → · Every quarter →

Lenz Therapeutics: EPS against the estimate, last 5 reportsLenz Therapeutics: EPS against the estimate, last 5 reportsEstimateReported−$0.69−$0.59Nov 25−$0.92−$1.16Mar 26−$1.07−$1.32May 26−$1.07−$1.02Aug 26−$0.95−$0.99Oct 26
Latest (Oct 26): Estimate −$0.95, Reported −$0.99.

Lenz Therapeutics' latest quarter

Lenz Therapeutics, Q3 2026: revenue $3.4M (-73% year over year), operating margin -972.8%, net loss $31.0M, operating cash flow −$22.3M. The chart follows the revenue to costs, profit and cash.

Questions

When does LENZ report earnings?

The next date is not set yet.

Does Lenz Therapeutics usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.